Neumora Therapeutics Up Over 16%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk
Neumora Has 2 More Chances With Navacaprant After Readout Miss, Mizuho Says
Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday
J.P. Morgan Maintains Neumora Therapeutics(NMRA.US) With Hold Rating
Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)
